We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | NYSE:ABBV | NYSE | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -1.74 | -1.03% | 167.80 | 4,064,703 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 169.11 | 166.74 | 168.95 | |||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 54.5B | 4.86B | 2.7529 | 60.95 | 296.41B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 00:52:15 | 7 | 166.82 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/1/2024 | 14:16 | DJN | AbbVie to Move Lutikizumab Into Phase 3 in Hidradenitis Suppurativa |
| 04/1/2024 | 14:29 | DJN | AbbVie, Umoja Biopharma Set CAR-T Cell Therapies Collaboration |
| 03/1/2024 | 23:17 | DJN | Abbvie Stock Edges Lower After CVS Says It Will Drop Humira From Some.. |
| 03/1/2024 | 22:59 | DJN | CVS Health To Cover Humira Biosimilars April 1 |
| 13/12/2023 | 16:29 | DJN | AbbVie Currently Up 11 Consecutive Days, on Pace for Longest Winning Streak.. |
| 12/12/2023 | 16:24 | DJN | AbbVie Currently Up 10 Consecutive Days, on Pace for Longest Winning Streak.. |
| 08/12/2023 | 15:28 | DJN | AbbVie Currently Up Eight Consecutive Days, on Track for Longest Winning.. |
| 07/12/2023 | 16:48 | DJN | AbbVie Currently Up Seven Consecutive Days, on Track for Longest Winning.. |
| 07/12/2023 | 15:27 | DJN | Trending: AbbVie to Buy Cerevel for $45 a Share |
| 06/12/2023 | 22:10 | DJN | AbbVie to Buy Cerevel Therapeutics for $8.7 Billion -- Update |
AbbVie (ABBV) Share Charts1 Year AbbVie Chart |
|
1 Month AbbVie Chart |
Intraday AbbVie Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
